Immune Modulation With PRaG-1 Treatment
NCT07002502
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Solid Cancer
Interventions
DRUG:
PRaG-1(cordycepin tablet)
Sponsor
Second Affiliated Hospital of Soochow University